The present project was designed to establish an animal model for studying the mechanism of drug neuroteratogenicity. Phenobarbital will be used but the model may apply to other agents as well. Since phenobarbital effect on the brain is rather general the studies will concentrate on behavioral deficits related to the hippocampus. Our preliminary findings in mice after prenatal phenobarbital treatment included the following: (1) deficits in behaviors related to hippocampal function; (2) alterations in hippocampal cholinergic receptors and their second messenger; and (3) reversal of the behavioral deficits by (a) transplantation of cholinergic, but not noradrenergic neurons, into the affected hippocampus and (b) by septal dopaminergic denervation. Our working hypothesis is that septohippocampal cholinergic impairment is one of the causal mechanisms underlying the phenobarbital induced behavioral deficits. Accordingly, we will conduct an extensive study on the relationship between the phenobarbital-induced alterations in the septohippocampal cholinergic innervations and the behavioral deficits using the following experimental approaches: 1. Study of the phenobarbital-induced alterations in the septohippocampal cholinergic innervations and its related eight-arm maze, spontaneous alternations and Morris maze behaviors. Consecutive studies will assess the extent of correction of the behavioral and the biochemical alterations by transplantation of cholinergic neurons into the impaired hippocampus. The transplant will be examined using immunocytochemistry. 2. An attempt will be made to enhance the septohippocampal cholinergic system of the phenobarbital-exposed animals by treatment with Nerve Growth Factor (NGF) during development. The possible behavioral and biochemical consequences of this treatment will be ascertained. 3. The septohippocampal cholinergic system and the behavior of the phenobarbital- exposed animals will be disinhibited by destroying the A10-septal dopaminergic innervations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA006670-03
Application #
2118867
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1991-02-01
Project End
1995-01-31
Budget Start
1993-02-01
Budget End
1995-01-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Hebrew University of Jerusalem
Department
Type
DUNS #
600044978
City
Jerusalem
State
Country
Israel
Zip Code
91904
Yanai, Joseph; Vatury, Ori; Slotkin, Theodore A (2002) Cell signaling as a target and underlying mechanism for neurobehavioral teratogenesis. Ann N Y Acad Sci 965:473-8
Yanai, J; Steingart, R A; Snapir, N et al. (2000) The relationship between neural alterations and behavioral deficits after prenatal exposure to heroin. Ann N Y Acad Sci 914:402-11
Weiss, S; Sawa, G H; Abdeen, Z et al. (1999) Substance abuse studies and prevention efforts among Arabs in the 1990s in Israel, Jordan and the Palestinian Authority--a literature review. Addiction 94:177-98
Steingart, R A; Barg, J; Maslaton, J et al. (1998) Pre- and postsynaptic alterations in the septohippocampal cholinergic innervations after prenatal exposure to drugs. Brain Res Bull 46:203-9
Yanai, J; Abu-Roumi, M; Silverman, W F et al. (1996) Neural grafting as a tool for the study and reversal of neurobehavioral birth defects. Pharmacol Biochem Behav 55:673-81
Yanai, J; Silverman, W F; Shamir, D (1995) An avian model for the reversal of 6-hydroxydopamine induced rotating behaviour by neural grafting. Neurosci Lett 187:153-6
Yanai, J; Doetchman, T; Laufer, N et al. (1995) Embryonic cultures but not embryos transplanted to the mouse's brain grow rapidly without immunosuppression. Int J Neurosci 81:21-6
Yanai, J; Pick, C G (1995) Neuron transplantation into mice hippocampus alters sensitivity to barbital narcosis. Brain Res Bull 38:93-8
Yanai, J; Shaanani, R; Pick, C G (1995) Altered brain sensitivity to ethanol in mice after MPTP treatment. Alcohol 12:127-30
Zamir, I; Yanai, J (1995) GTPase activity in mouse hippocampus membranes following prenatal exposure to heroin and phenobarbital. Biochem Pharmacol 50:127-30

Showing the most recent 10 out of 22 publications